What’s Next in Hepatology? Breakthroughs in Prediction, Diagnosis, and Patient Outcomes
Nov
2026
Description
This session showcases emerging prediction and diagnostic tools across hepatology, including AI-assisted guideline synthesis, novel fibrosis risk scores, and exercise-based interventions in cirrhosis.
Presentations
5:00 PM
- 5:15 PM
Convention Center - Bluebird Ballroom 1B
LiverRisk score for early detection of liver fibrosis in the general population: the LiverScreen Implementation study
Adrià Juanola | Abstract Presenter
5:15 PM
- 5:30 PM
Convention Center - Bluebird Ballroom 1B
A Multi-Agent AI System for Maintaining Liver Disease Guidelines: Evidence Synthesis, Consensus Building, and Clinical Impact
Wang Zixing, PhD | Abstract Presenter
5:30 PM
- 5:45 PM
Convention Center - Bluebird Ballroom 1B
The ABCD score: a laboratory-free, sex-specific prediction model for community-level steatotic liver disease screening — development and external validation in India
Kanica Kaushal, MBBS, MD | Abstract Presenter
5:45 PM
- 6:00 PM
Convention Center - Bluebird Ballroom 1B
Supervised exercise training improves skeletal muscle mitochondrial function and physical performance in cirrhosis: A prospective randomized controlled trial
Annette Bellar, PhD | Abstract Presenter
6:00 PM
- 6:15 PM
Convention Center - Bluebird Ballroom 1B
Comparison of Endoscopic Ultrasound-Guided Versus Percutaneous Liver Biopsy: A Systematic Review and Meta-Analysis
Ramsha A Khan, MD | Abstract Presenter
6:15 PM
- 6:30 PM
Convention Center - Bluebird Ballroom 1B
Prevalence and Predictors of Recurrent HELLP Syndrome: A Multicenter Retrospective Study Across Three Hospital Systems
Jacqueline S Slobin | Abstract Presenter
